Cómo contactar con el centro
Centro HCP

en el marco del Plan de Enfermedades Raras 2006-2011, reetiquetado en 2017. OPHTARA es
Consorcio único que forma parte de ERN-EYE con 5 hospitales universitarios de París: Necker
(sitio coordinador), Pitié Salpetrière, HEGP, Cochin y Hôtel Dieu (sitios componentes).
Imagen: Celette
Contacto
OPHTARA – AP-HP, Hôpital Necker-Enfants Malades, Paris, France
Equipo

Pr Dominique BREMOND-GIGNAC
Francia

Pr Alejandra Daruich-Matet
Francia

Pr Matthieu Robert
Francia
Los ensayos clínicos

Open-label, Single-arm, Multicenter Study to Assess the Safety of Cystadrops® in Pediatric Cystinosis Patients From 6 Months to Less Than 2 Years Old

Study of the efficacy of Befizal® 200mg in the treatment of Leber’s hereditary optic neuropathy

Function of the Pigment Epithelium in Patients With Type 1 Neurofibromatosis (NEF-1)

Interest of Intravitreal Injections of Anti-VEGF as Initial and Adjuvant Treatment in Coats Disease.

A phase II, open-label, efficacy study of daily administration of sodium valproate in patients clinically affected by Wolfram syndrome due to monogenic mutation.

A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber’s Hereditary Optic Neuropathy (LHON).

Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult Patients

An International Prospective Natural History Study in Children With a Type II Collagen Disorder With Short Stature

Genetic Study of Patients Suffering From Congenital Amaurosis of Leber or From an Early Severe Retinal Dystrophy.

Long-Term Non-Interventional Latanoprost Study

Genetic Decryption of Leber Congenital Amaurosis (LCA) in a Large Cohort of Independent Families.